FIELD: medicine.
SUBSTANCE: invention can be used both for studying mechanisms of development of paroxysmal states with progredient course (epilepsy) and for screening (selection) of novel medications, possessing potential anti-epileptic activity. For this purpose, rats are given fractional injections of convulsant 1.5-pentamethylentetrazole (pentylenetetrazole) with 15 minute interval in dose 10 mg/kg in volume 0.1 ml solution per 100 g of body weight until fist generalised convulsive seizure develops. After that calculated is threshold dose of convulsant reflecting base level of CNS excitability for each animal. When sessions are repeated, dynamics of change of initial dose of pentylenetetrazole is taken into account, interval between sessions of pentylenetetrazole titration can constitute from 24 and more than 168 hours.
EFFECT: method ensures high accuracy of evaluation of change of seizure development threshold due to the fact that expression of modelled progredient state can be changed at any stage of carrying out chronic research without application of special methods of examination.
1 tbl, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DISCOVERING ANTICONVULSANT ACTION OF CITICOLINE IN PENTYLENETETRAZOLE KINDLING MODEL INVOLVING MALE C57B1/6 MICE | 2014 |
|
RU2567275C1 |
METHOD OF DETECTING ANTICONVULSANT ACTION OF SODIUM CITICOLINE AND VALPROATE WHEN APPLYING THEM TOGETHER ON MODEL OF ACUTE GENERALIZED CONVULSIONS CAUSED BY PENTYLENETETRAZOLE IN WISTAR MALE RATS | 2015 |
|
RU2600477C1 |
METHOD FOR PREDICTING AND TREATING IDIOPATHIC GENERALIZED EPILEPSY IN CHILDREN | 2005 |
|
RU2297176C2 |
METHOD OF CHILDREN ABSENTIA TREATMENT ASSOCIATED WITH IDIOPATHIC GENERALISED EPILEPSY | 2005 |
|
RU2329761C2 |
METHOD FOR PREDICTING REMISSION OF EPILEPSY | 2003 |
|
RU2238029C1 |
4-BENZOYLPYRIDINE OXIME DERIVATIVES HAVING ANTICONVULSANT ACTIVITY AS AGENTS FOR TREATMENT OF EPILEPSY AND PAROXYSMAL STATES | 2016 |
|
RU2643091C2 |
METHOD FOR TREATMENT OF EPILEPTIC PATIENTS | 2005 |
|
RU2314097C2 |
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING PAROXYSMAL CONDITIONS | 2011 |
|
RU2469722C1 |
ANTIEPILEPTIC AGENT WITH NOOTROPIC EFFECT | 2001 |
|
RU2201226C1 |
METHOD FOR EVALUATING EPILEPSY PHARMACOTHERAPY EFFECTIVENESS | 2000 |
|
RU2164688C1 |
Authors
Dates
2011-11-20—Published
2009-12-28—Filed